Zhejiang East Asia Pharmaceutical Co., Ltd.
SHH: 605177.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Cheng Chi
- Employees
- 1,435
- Headquarters
- Taizhou, China
- IPO year
- 2020
- Market cap
- CN¥2.4B
- Website
- http://www.eapharm.cn
Loading 605177…
Loading profile data…Frequently asked questions about 605177
What does Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) do?
Zhejiang East Asia Pharmaceutical Co., Ltd. engages in the manufacture and distribution of active pharmaceutical ingredients (API), tablets, granules and capsules. The company was founded in 1992 and is headquartered in Taizhou, China.
Where does 605177.SS trade?
Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) trades on the Shanghai Stock Exchange.
What sector is 605177.SS in?
Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Zhejiang East Asia Pharmaceutical Co., Ltd.?
Cheng Chi is the chief executive officer of Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS).
Where is Zhejiang East Asia Pharmaceutical Co., Ltd. headquartered?
Zhejiang East Asia Pharmaceutical Co., Ltd. is headquartered in China.
Does 605177.SS pay a dividend?
Yes — Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) paid a trailing twelve-month dividend of CNY 0.33 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 605177.SS go public?
Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) completed its initial public offering in 2020.